ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer.

ABSTRACT:

SUBMITTER: Matikas A 

PROVIDER: S-EPMC7910736 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature